253 related articles for article (PubMed ID: 30513351)
1. Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides.
Erdei AI; Borbély A; Magyar A; Szűcs E; Ötvös F; Gombos D; Al-Khrasani M; Stefanucci A; Dimmito MP; Luisi G; Mollica A; Benyhe S
Peptides; 2019 Feb; 112():106-113. PubMed ID: 30513351
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.
Gündüz O; Rizzi A; Baldisserotto A; Guerrini R; Spagnolo B; Gavioli EC; Kocsis L; Magyar A; Benyhe S; Borsodi A; Calò G
Eur J Pharmacol; 2006 Jun; 539(1-2):39-48. PubMed ID: 16682024
[TBL] [Abstract][Full Text] [Related]
3. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S
Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951
[TBL] [Abstract][Full Text] [Related]
4. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
[TBL] [Abstract][Full Text] [Related]
5. Selective and high affinity labeling of neuronal and recombinant nociceptin receptors with the hexapeptide radioprobe [(3)H]Ac-RYYRIK-ol.
Bojnik E; Farkas J; Magyar A; Tömböly C; Güçlü U; Gündüz O; Borsodi A; Corbani M; Benyhe S
Neurochem Int; 2009 Dec; 55(7):458-66. PubMed ID: 19414055
[TBL] [Abstract][Full Text] [Related]
6. In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor.
Gunduz O; Sipos F; Spagnolo B; Kocsis L; Magyar A; Orosz G; Borsodi A; Calò G; Benyhe S
Neurosignals; 2006-2007; 15(2):91-101. PubMed ID: 16874009
[TBL] [Abstract][Full Text] [Related]
7. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
[TBL] [Abstract][Full Text] [Related]
8. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
[TBL] [Abstract][Full Text] [Related]
10. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
Kapusta DR; Burmeister MA; Calo' G; Guerrini R; Gottlieb HB; Kenigs VA
J Pharmacol Exp Ther; 2005 Aug; 314(2):643-51. PubMed ID: 15855356
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological characterization of three opioid-nociceptin hybrid peptide ligands reveals substantially differing modes of their actions.
Erdei AI; Borbély A; Magyar A; Taricska N; Perczel A; Zsíros O; Garab G; Szűcs E; Ötvös F; Zádor F; Balogh M; Al-Khrasani M; Benyhe S
Peptides; 2018 Jan; 99():205-216. PubMed ID: 29038035
[TBL] [Abstract][Full Text] [Related]
12. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
[TBL] [Abstract][Full Text] [Related]
13. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
[TBL] [Abstract][Full Text] [Related]
14. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
Mason SL; Ho M; Nicholson J; McKnight AT
Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
[TBL] [Abstract][Full Text] [Related]
18. Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ.
Berger H; Albrecht E; Wallukat G; Bienert M
Br J Pharmacol; 1999 Feb; 126(3):555-8. PubMed ID: 10188961
[TBL] [Abstract][Full Text] [Related]
19. Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides.
Kocsis L; Orosz G; Magyar A; Al-Khrasani M; Kató E; Rónai AZ; Bes B; Meunier JC; Gündüz O; Tóth G; Borsodi A; Benyhe S
Regul Pept; 2004 Nov; 122(3):199-207. PubMed ID: 15491792
[TBL] [Abstract][Full Text] [Related]
20. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]